Protagonist Therapeutics, Inc. Profile Avatar - Palmy Investing

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injec…

Biotechnology
US, Newark [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of PTGX's Analysis
CIK: 1377121 CUSIP: 74366E102 ISIN: US74366E1029 LEI: - UEI: -
Secondary Listings
PTGX has no secondary listings inside our databases.